Biomea Fusion Inc (BMEA)
4.23
-0.12
(-2.76%)
USD |
NASDAQ |
Jul 05, 16:00
4.225
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion Research and Development Expense (Annual): 102.55M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 102.55M |
| December 31, 2022 | 62.71M |
| December 31, 2021 | 28.00M |
| Date | Value |
|---|---|
| December 31, 2020 | 3.671M |
| December 31, 2019 | 1.092M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
1.092M
Minimum
2019
102.55M
Maximum
2023
39.60M
Average
28.00M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Geron Corp | 125.05M |
| Asensus Surgical Inc | 37.02M |
| Geovax Labs Inc | 20.72M |
| Syndax Pharmaceuticals Inc | 163.03M |
| Cartesian Therapeutics Inc | 71.84M |